Thinking outside the box: indirect myc modulation in canine b-cell lymphoma

HIGHLIGHTS

• What: Our study offers valuable insights into the mechanisms of action of BI2536 and MZ1 in cBCL and highlights their potential as targeted therapies for this cancer subtype.
• Who: Luca Licenziato and collaborators from the Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, SwitzerlandDepartment of Biomedical Sciences, College of Veterinary Medicine, Cornell University have published the research work: Thinking Outside the Box: Indirect Myc Modulation in Canine B-Cell Lymphoma, in the Journal: Animals 2024, 14, x FOR PEER REVIEW Animals 2024, 14, 1466 of /2024/

SUMMARY

Of 12 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.